Concepedia
Statistics
Publications
46
Citations
3.1K
H-Index
28
Active since
2002
Affiliations
Washington State University(Current)
Blueprint Medicines (United States)
Dana-Farber Cancer Institute
University of Michigan
Stanford University
Huimin Lin is an author at Washington State University specializing in medicine, pharmacology, and oncology.
Publications per year
2002–2024
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
H. Miles Prince, Youn H. Kim, Reinhard Dummer et al. · The Lancet · 2017 · 580 citations
Medicine, Hematology, Oncology +12
Metabolism of Flavonoids via Enteric Recycling: Role of Intestinal Disposition
Jun Chen, Huimin Lin, Ming Hu · Journal of Pharmacology and Experimental Therapeutics · 2003 · 244 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Self-Amplification of Tumor Oxidative Stress with Degradable Metallic Complexes for Synergistic Cascade Tumor Therapy
Gui Chen, Yuanyuan Yang, Qing Xu et al. · Nano Letters · 2020 · 233 citations
Life Sciences, Oncology, Pharmacology +17
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial
Daniel J. DeAngelo, Deepti Radia, Tracy I. George et al. · Nature Medicine · 2021 · 150 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +14
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
Jason Gotlib, Andreas Reiter, Deepti Radia et al. · Nature Medicine · 2021 · 147 citations · Full text
Medicine, Oncology, Pharmacology +12
1–5 of 46